Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis

NCT03695705 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis, Liver

Interventions

DRUG: Rifaximin 550 mg twice a day and Norfloxacin 400 mg once a day

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh